Laura M. Spring

Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models

Ioanna Keklikoglou, Chiara Cianciaruso, Esra Güç et al. · Nature Cell Biology · 2018 · 532 citations · Full text

Medicine, Cancer Biology, Oncology +14

Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer

Rosaria Condorelli, Laura M. Spring, Joyce O’Shaughnessy et al. · Annals of Oncology · 2017 · 404 citations · Full text

Medicine, Cancer Biology, Oncology +16

Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

Otto Metzger, Giuseppe Viale, Shayna Stein et al. · Cancer Discovery · 2021 · 240 citations · Full text

Medicine, Cancer Biology, Oncology +15

Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor–Positive, <i>ERBB2</i>-Negative Metastatic Breast Cancer

Sara M. Tolaney, Romualdo Barroso‐Sousa, Tanya E. Keenan et al. · JAMA Oncology · 2020 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer

Laura M. Spring, Rachel A. Greenup, Andrzej Niemierko et al. · Journal of the National Comprehensive Cancer Network · 2017 · 153 citations · Full text

Medicine, Cancer Biology, Oncology +17